Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT

Background Recurrence or persistence of symptoms after interventions to treat stress urinary incontinence in women is common, but without robust evidence to base treatment recommendations. Objectives To investigate whether endoscopic or surgical treatments for stress urinary incontinence in women ar...

Full description

Saved in:
Bibliographic Details
Main Authors: Caroline Pope, Madeleine Cochrane, Clare Clement, Yumeng Liu, Sangeetha Paramasivan, Sian Noble, Stephanie J MacNeill, Amanda L Lewis, Jodi Taylor, Bethanie Fitzgerald, Nikki Cotterill, Tamsin Greenwell, Hashim Hashim, Swati Jha, Nikesh Thiruchelvam, Philip Toozs-Hobson, Alison White, Wael Agur, J Athene Lane, Marcus Drake
Format: Article
Language:English
Published: NIHR Journals Library 2025-07-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/AKAK8992
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849421264345628672
author Caroline Pope
Madeleine Cochrane
Clare Clement
Yumeng Liu
Sangeetha Paramasivan
Sian Noble
Stephanie J MacNeill
Amanda L Lewis
Jodi Taylor
Bethanie Fitzgerald
Nikki Cotterill
Tamsin Greenwell
Hashim Hashim
Swati Jha
Nikesh Thiruchelvam
Philip Toozs-Hobson
Alison White
Wael Agur
J Athene Lane
Marcus Drake
author_facet Caroline Pope
Madeleine Cochrane
Clare Clement
Yumeng Liu
Sangeetha Paramasivan
Sian Noble
Stephanie J MacNeill
Amanda L Lewis
Jodi Taylor
Bethanie Fitzgerald
Nikki Cotterill
Tamsin Greenwell
Hashim Hashim
Swati Jha
Nikesh Thiruchelvam
Philip Toozs-Hobson
Alison White
Wael Agur
J Athene Lane
Marcus Drake
author_sort Caroline Pope
collection DOAJ
description Background Recurrence or persistence of symptoms after interventions to treat stress urinary incontinence in women is common, but without robust evidence to base treatment recommendations. Objectives To investigate whether endoscopic or surgical treatments for stress urinary incontinence in women are effective and cost-effective. Design A multicentre, unblinded, parallel-group randomised controlled trial. Setting Fifteen centres across the United Kingdom. Participants Adult women with recurrent or persistent stress urinary incontinence. Intervention Individual randomisation to endoscopic (urethral bulking) or surgical (autologous sling, colposuspension, artificial urinary sphincter) interventions. Women randomised to surgery chose their operative intervention. Main outcomes Primary outcome self-reported International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form at 1 year post randomisation. Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, Patient Global Impression of Improvement and Pelvic Organ Prolapse/Urinary Incontinence Sexual questionnaires up to 3 years post randomisation, operative assessment measures and adverse events, cost-effectiveness from National Health Service and societal perspectives (quality-adjusted life-years and International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form) at 1 year, and a secondary care perspective (quality-adjusted life-years) at 3 years. Semistructured qualitative interviews at baseline (post randomisation), follow-up (3–6 months) and longer-term (12 and 36 months), to explore stress urinary incontinence generally, the acceptability and attitudes to treatments and to improve understanding of outcomes. Qualitative interviews with clinicians at baseline were focused on potential difficulties of recruitment and optimising patient-facing information and training materials for clinicians. Results Fifty-five women were deemed eligible after screening (n = 328 screened) from October 2019 to June 2022. Twenty-four eligible women consented, and 23 were randomised (between January 2020 and July 2022) from 8 sites with the average age of 57 years (standard deviation: 10.7) and all self-reported ‘white’ ethnicity. Participants reported a median International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form score at baseline of 16 (interquartile range: 13–19) and mean post-void residual volume of 4.64 ml (standard deviation: 8.45). Eleven participants received their allocated intervention, 2 participants withdrew prior to receiving their intervention and 10 were waiting for their intervention when the study closed. The most common reason for declining participation was a treatment preference (n = 14). Recruitment training sessions and recruitment tips documents were developed and implemented to address challenges centred around patient treatment preferences and clinicians’ equipoise. However, the most important recruitment challenge was the low number of eligible patients, driven primarily by the COVID-19 pandemic preventing referrals and surgery, and related wider issues in the National Health Service which led to study closure in January 2023. Conclusion In its early stages, the initial recruitment rate was on target (four participants randomised in the first 3 months of recruitment), but once the pandemic started, the study was unable to recruit and so closed early. The main limitation was the occurrence of the global pandemic soon after the commencement of recruitment, profoundly affecting service delivery and patient presentations. Under normal healthcare service conditions, the study may be deliverable. Limitations Failure to recruit under pandemic conditions rendered the study unfeasible. Future research Practical experience with the study and development of patient-facing and staff training materials will help delivery of the study once patient referrals and healthcare services fully return to normal. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 17/95/03. Plain language summary Urinary leakage with physical activity, or stress urinary incontinence, affects about a quarter of women after pregnancy and at other times. Treatment options include surgery or a bulking injection into the bladder, but symptoms can continue after treatment, known as recurrent, or persistent, stress urinary incontinence. It is not known which treatment is best for women who have already had a treatment. This study aimed to establish whether an operation or endoscopic bulking injections are better for treating recurrent or persistent stress urinary incontinence. The study aim was for 250 women across the United Kingdom with recurrent stress urinary incontinence to take part, and recruitment started in January 2020. Fifty-five women from 15 hospitals were identified as suitable, and 23 women consented to take part and were randomly allocated (by chance) to a treatment group (surgery or bulking injection). Women in the surgery group decided which operation to have in consultation with their doctor. Women were asked to complete questionnaires at the start of the study, and again later, covering general health, urinary symptoms and the effect of those symptoms on everyday life. Some women were interviewed to explore their attitudes to the treatments and understand how they manage after having treatment. The most common reason women gave for not wanting to take part was that they had a treatment preference. Eleven women received their allocated treatment. However, the COVID pandemic and wider issues within the National Health Service made it impossible to identify enough suitable women, and treatments were prevented for a long period, so the study closed early in January 2023. Unfortunately, it is not possible to make conclusions from the results collected due to the low number of women in the study.
format Article
id doaj-art-e033f382c70a4c93b401b9b8c7020b8e
institution Kabale University
issn 2046-4924
language English
publishDate 2025-07-01
publisher NIHR Journals Library
record_format Article
series Health Technology Assessment
spelling doaj-art-e033f382c70a4c93b401b9b8c7020b8e2025-08-20T03:31:30ZengNIHR Journals LibraryHealth Technology Assessment2046-49242025-07-0110.3310/AKAK899217/95/03Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCTCaroline Pope0Madeleine Cochrane1Clare Clement2Yumeng Liu3Sangeetha Paramasivan4Sian Noble5Stephanie J MacNeill6Amanda L Lewis7Jodi Taylor8Bethanie Fitzgerald9Nikki Cotterill10Tamsin Greenwell11Hashim Hashim12Swati Jha13Nikesh Thiruchelvam14Philip Toozs-Hobson15Alison White16Wael Agur17J Athene Lane18Marcus Drake19Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKBristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKCentre for Health and Clinical Research, University of the West of England, Bristol, UKDepartment of Urology, University College London Hospitals NHS Foundation Trust, London, UKBristol Urological Institute, Southmead Hospital, North Bristol NHS Trust, Bristol, UKDepartment of Urogynaecology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UKDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UKDepartment of Urogynaecology, Birmingham Women’s and Children’s Hospital, NHS Foundation Trust, Birmingham, UKPatient and Public Involvement Representative, Bristol, UKDepartment of Obstetrics and Gynaecology, NHS Ayrshire & Arran, University Hospital Crosshouse, Kilmarnock, UKDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UKBackground Recurrence or persistence of symptoms after interventions to treat stress urinary incontinence in women is common, but without robust evidence to base treatment recommendations. Objectives To investigate whether endoscopic or surgical treatments for stress urinary incontinence in women are effective and cost-effective. Design A multicentre, unblinded, parallel-group randomised controlled trial. Setting Fifteen centres across the United Kingdom. Participants Adult women with recurrent or persistent stress urinary incontinence. Intervention Individual randomisation to endoscopic (urethral bulking) or surgical (autologous sling, colposuspension, artificial urinary sphincter) interventions. Women randomised to surgery chose their operative intervention. Main outcomes Primary outcome self-reported International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form at 1 year post randomisation. Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, Patient Global Impression of Improvement and Pelvic Organ Prolapse/Urinary Incontinence Sexual questionnaires up to 3 years post randomisation, operative assessment measures and adverse events, cost-effectiveness from National Health Service and societal perspectives (quality-adjusted life-years and International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form) at 1 year, and a secondary care perspective (quality-adjusted life-years) at 3 years. Semistructured qualitative interviews at baseline (post randomisation), follow-up (3–6 months) and longer-term (12 and 36 months), to explore stress urinary incontinence generally, the acceptability and attitudes to treatments and to improve understanding of outcomes. Qualitative interviews with clinicians at baseline were focused on potential difficulties of recruitment and optimising patient-facing information and training materials for clinicians. Results Fifty-five women were deemed eligible after screening (n = 328 screened) from October 2019 to June 2022. Twenty-four eligible women consented, and 23 were randomised (between January 2020 and July 2022) from 8 sites with the average age of 57 years (standard deviation: 10.7) and all self-reported ‘white’ ethnicity. Participants reported a median International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form score at baseline of 16 (interquartile range: 13–19) and mean post-void residual volume of 4.64 ml (standard deviation: 8.45). Eleven participants received their allocated intervention, 2 participants withdrew prior to receiving their intervention and 10 were waiting for their intervention when the study closed. The most common reason for declining participation was a treatment preference (n = 14). Recruitment training sessions and recruitment tips documents were developed and implemented to address challenges centred around patient treatment preferences and clinicians’ equipoise. However, the most important recruitment challenge was the low number of eligible patients, driven primarily by the COVID-19 pandemic preventing referrals and surgery, and related wider issues in the National Health Service which led to study closure in January 2023. Conclusion In its early stages, the initial recruitment rate was on target (four participants randomised in the first 3 months of recruitment), but once the pandemic started, the study was unable to recruit and so closed early. The main limitation was the occurrence of the global pandemic soon after the commencement of recruitment, profoundly affecting service delivery and patient presentations. Under normal healthcare service conditions, the study may be deliverable. Limitations Failure to recruit under pandemic conditions rendered the study unfeasible. Future research Practical experience with the study and development of patient-facing and staff training materials will help delivery of the study once patient referrals and healthcare services fully return to normal. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 17/95/03. Plain language summary Urinary leakage with physical activity, or stress urinary incontinence, affects about a quarter of women after pregnancy and at other times. Treatment options include surgery or a bulking injection into the bladder, but symptoms can continue after treatment, known as recurrent, or persistent, stress urinary incontinence. It is not known which treatment is best for women who have already had a treatment. This study aimed to establish whether an operation or endoscopic bulking injections are better for treating recurrent or persistent stress urinary incontinence. The study aim was for 250 women across the United Kingdom with recurrent stress urinary incontinence to take part, and recruitment started in January 2020. Fifty-five women from 15 hospitals were identified as suitable, and 23 women consented to take part and were randomly allocated (by chance) to a treatment group (surgery or bulking injection). Women in the surgery group decided which operation to have in consultation with their doctor. Women were asked to complete questionnaires at the start of the study, and again later, covering general health, urinary symptoms and the effect of those symptoms on everyday life. Some women were interviewed to explore their attitudes to the treatments and understand how they manage after having treatment. The most common reason women gave for not wanting to take part was that they had a treatment preference. Eleven women received their allocated treatment. However, the COVID pandemic and wider issues within the National Health Service made it impossible to identify enough suitable women, and treatments were prevented for a long period, so the study closed early in January 2023. Unfortunately, it is not possible to make conclusions from the results collected due to the low number of women in the study.https://doi.org/10.3310/AKAK8992humansadultfemalemiddle agedquality-adjusted life-yearsresidual volumestress urinary incontinenceurinary incontinencesurveys and questionnairesprolapserandomised controlled trial
spellingShingle Caroline Pope
Madeleine Cochrane
Clare Clement
Yumeng Liu
Sangeetha Paramasivan
Sian Noble
Stephanie J MacNeill
Amanda L Lewis
Jodi Taylor
Bethanie Fitzgerald
Nikki Cotterill
Tamsin Greenwell
Hashim Hashim
Swati Jha
Nikesh Thiruchelvam
Philip Toozs-Hobson
Alison White
Wael Agur
J Athene Lane
Marcus Drake
Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
Health Technology Assessment
humans
adult
female
middle aged
quality-adjusted life-years
residual volume
stress urinary incontinence
urinary incontinence
surveys and questionnaires
prolapse
randomised controlled trial
title Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
title_full Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
title_fullStr Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
title_full_unstemmed Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
title_short Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
title_sort challenges to overcome in a randomised trial for proper understanding of recurrent stress urinary incontinence treatment in women the pursuit rct
topic humans
adult
female
middle aged
quality-adjusted life-years
residual volume
stress urinary incontinence
urinary incontinence
surveys and questionnaires
prolapse
randomised controlled trial
url https://doi.org/10.3310/AKAK8992
work_keys_str_mv AT carolinepope challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT madeleinecochrane challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT clareclement challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT yumengliu challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT sangeethaparamasivan challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT siannoble challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT stephaniejmacneill challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT amandallewis challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT joditaylor challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT bethaniefitzgerald challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT nikkicotterill challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT tamsingreenwell challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT hashimhashim challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT swatijha challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT nikeshthiruchelvam challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT philiptoozshobson challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT alisonwhite challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT waelagur challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT jathenelane challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct
AT marcusdrake challengestoovercomeinarandomisedtrialforproperunderstandingofrecurrentstressurinaryincontinencetreatmentinwomenthepursuitrct